CAPR - Capricor Therapeutics, Inc.

NasdaqCM - NasdaqCM Delayed price. Currency in USD
2.11
-0.06 (-2.92%)
At close: 4:00PM EST

2.20 +0.09 (4.27%)
After hours: 7:14PM EST

Stock chart is not supported by your current browser
Previous close2.17
Open2.17
Bid2.01 x 200
Ask2.65 x 2000
Day's range2.10 - 2.19
52-week range0.63 - 4.25
Volume320,358
Avg. volume2,094,544
Market cap52.962M
Beta-0.11
PE ratio (TTM)N/A
EPS (TTM)-0.82
Earnings date8 Nov 2017 - 13 Nov 2017
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est6.50
Trade prices are not sourced from all markets
  • Associated Press13 days ago

    Capricor reports 3Q loss

    The Beverly Hills, California-based company said it had a loss of 12 cents per share. The biotechnology company posted revenue of $313,300 in the period. Its adjusted revenue was $313,000. In the final ...

  • Capricor Therapeutics (CAPR) Looks Good: Stock Adds 13.9% in Session
    Zacks2 months ago

    Capricor Therapeutics (CAPR) Looks Good: Stock Adds 13.9% in Session

    Capricor Therapeutics (CAPR) was a big mover last session, as the company saw its shares rise almost 14% on the day amid huge volumes.

  • We're sorry this is all we were able to find about this topic.

By using Yahoo you agree that Yahoo and partners may use Cookies for personalisation and other purposes